# Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042)

> **NCT00966030** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 50 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** MK0974 tablet
- **DRUG:** Comparator: MK0974 liquid filled capsule

## Key facts

- **NCT ID:** NCT00966030
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00966030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00966030, "Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00966030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*